drugset / Trial / NCT02048917

Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies

NCT02048917

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to find an optimal smoking cessation strategy in patients undergoing therapy for lung and head and neck cancers at selected cancer centers in Kentucky by delivering high quality smoking cessation to all enrolled patients. This study will also examine the feasibility of routinely implementing an array of smoking cessation strategies for this patient population.

Timeline

Start
2014-07-22
Primary completion
2019-05-15
Completion
2019-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule
Subject Varenicline Small molecule